MoneyWorks4Me

Indoco Remedies informs about execution of equity purchase agreement

06 Jun 2023 Evaluate

In compliance with the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that the Board of the Directors of the Company at their meeting held on June 5, 2023, approved the acquisition of 85% equity stake in FPP Holding Company, LLC (‘FPP Holding’), a company registered in Delaware, USA (‘Acquisition’). Consequently, Indoco Remedies (Company) has executed Equity Purchase Agreement on June 5, 2023 for the Acquisition. It has enclosed a press release in this regard and details as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFO/CMD/4/2015 dated September 9, 2015 in Annexure ‘A’ and ‘B’.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..